Vnitr Lek 2008, 54(10):948-949

Srdeční amyloidóza - editorial

P. Gregor
III. interní - kardiologická klinika 3. lékařské fakulty UK a FN Královské Vinohrady Praha, přednosta prof. MUDr. Petr Widimský, DrSc., FESC

Received: June 30, 2008; Published: October 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gregor P. Srdeční amyloidóza - editorial. Vnitr Lek. 2008;54(10):948-949.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bellavia D, Pellikka PA, Abraham TP et al. Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography. Am J Cardiol 2008; 101: 1039-1045. Go to original source... Go to PubMed...
    2. Dubrey SW, Cha K, Simms RW et al. Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis. Am J Cardiol 1996; 77: 313-319. Go to original source... Go to PubMed...
    3. Dubrey SW, Cha K, Skinner M et al. Familiar and primary cardiac amyloidosis: echocardiographically similar diseases with distincly different clinical outcomes. Heart 1997; 78: 74-81. Go to original source... Go to PubMed...
    4. Felker GM, Thompson RE, Hare JM et al. Underlying cause and long term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342: 1077-1082. Go to original source... Go to PubMed...
    5. Gertz MA, Lacy MQ, Dispenzieri A. Amyloidosis. Hematol Oncol Clin North Am 1999; 13: 1211-1233. Go to original source... Go to PubMed...
    6. Gutierrez PS, Fernandes F, Mady C et al. Clinical, electrocardiographic and echocardiographic findigs in significant cardiac amyloidosis detected only at necropsy: comparison with CASE diagnosed in life. Arq Bras Cardiol 2008; 90: 191-196. Go to original source... Go to PubMed...
    7. Kristen AV, Perz JB, Schonland SO et al. Non-invasive predictors of surfoval in cardiac amyloidosis. Eur J Heart Fail 2008; 9: 617-624. Go to original source... Go to PubMed...
    8. Kuchynka P, Paleček T, Šimek S et al. Izolovaná forma srdeční amyloidózy v podobě počínající infiltrativní kardiomyopatie bez restriktivní fyziologie. Vnitř Lék 2008; 54: 1010-1013. Go to PubMed...
    9. Murphy RT, Ratliff NB, Lever HM et al. Use of percutaneous transluminal septal myocardial ablation for relief of outflow tract obstruction in cardiac amyloidosis: a novel therapeutic target. Cathe Cardiovasc Interv 2006; 68: 637-641. Go to original source... Go to PubMed...
    10. Selvanayagam JB, Hawkins PN, Pau B et al. Evaluation and Management of the cardiac amyloidosis. J Am Coll Cardiol 2007; 50: 2101-2110. Go to original source... Go to PubMed...
    11. Vogelsberg H, Mahrholdt H, Deluigi CC et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 2008; 51: 1022-1030. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.